1. Blinded by the smoke?

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. Improving the monitoring of adverse reactions

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. Vitamin preparations: recommendations for use

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. Flumazenil: a safe, specific, fastacting benzodiazepine antagonist

   Newsletter Article 12 February 2013 Pages: 3 - 4

5. Alprazolam withdrawal

   Newsletter Article 12 February 2013 Pages: 4 - 4

6. Amiodarone

   Newsletter Article 12 February 2013 Pages: 4 - 4

7. Antidepressants, monoamine oxidase inhibitors

   Newsletter Article 12 February 2013 Pages: 4 - 5

8. Antibiotics see Cyclosporin interaction

   Newsletter Article 12 February 2013 Pages: 5 - 5

9. Antimalarials

   Newsletter Article 12 February 2013 Pages: 5 - 5

10. Antipsychotics

    Newsletter Article 12 February 2013 Pages: 5 - 5

11. Atenolol see Propanolol/atenolol

    Newsletter Article 12 February 2013 Pages: 5 - 5

12. Azathioprine

    Newsletter Article 12 February 2013 Pages: 5 - 5

13. Beta-agonists

    Newsletter Article 12 February 2013 Pages: 5 - 6

14. Bleomycin

    Newsletter Article 12 February 2013 Pages: 6 - 6

15. Carbamazepine see Progabide interaction

    Newsletter Article 12 February 2013 Pages: 6 - 6

16. Cefamandole

    Newsletter Article 12 February 2013 Pages: 6 - 6

17. Charcoal

    Newsletter Article 12 February 2013 Pages: 6 - 6

18. Corticosteroids

    Newsletter Article 12 February 2013 Pages: 6 - 6

19. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 6 - 6

20. Cyclosporin interaction

    Newsletter Article 12 February 2013 Pages: 6 - 7

21. Desipramine

    Newsletter Article 12 February 2013 Pages: 7 - 7

22. Diamorphine dependence

    Newsletter Article 12 February 2013 Pages: 7 - 7

23. Diphenhydramine overdose

    Newsletter Article 12 February 2013 Pages: 7 - 7

24. Dothiepin

    Newsletter Article 12 February 2013 Pages: 7 - 7

25. H2-antagonists

    Newsletter Article 12 February 2013 Pages: 7 - 7

26. Heparin

    Newsletter Article 12 February 2013 Pages: 7 - 7

27. Ibuprofen

    Newsletter Article 12 February 2013 Pages: 7 - 8

28. Ibuprofen/indomethacin

    Newsletter Article 12 February 2013 Pages: 8 - 8

29. Ifosfamide

    Newsletter Article 12 February 2013 Pages: 8 - 8

30. Indomethacin see ibuprofen/indomethacin

    Newsletter Article 12 February 2013 Pages: 8 - 8

31. Lidocaine

    Newsletter Article 12 February 2013 Pages: 8 - 8

32. Lithium

    Newsletter Article 12 February 2013 Pages: 8 - 8

33. Mesalazine see Sulphasalazine/mesalazine

    Newsletter Article 12 February 2013 Pages: 8 - 8

34. Molindone

    Newsletter Article 12 February 2013 Pages: 8 - 9

35. Papaveretum

    Newsletter Article 12 February 2013 Pages: 9 - 9

36. Pemoline overdose

    Newsletter Article 12 February 2013 Pages: 9 - 9

37. Phenobarbital

    Newsletter Article 12 February 2013 Pages: 9 - 9

38. Phenytoin see Progabide interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

39. Progabide interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

40. Propranolol/atenolol

    Newsletter Article 12 February 2013 Pages: 10 - 10

41. Pristinamycin see Cyclosporin interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

42. Sodium aurothiomalate

    Newsletter Article 12 February 2013 Pages: 10 - 10

43. Sodium phosphate

    Newsletter Article 12 February 2013 Pages: 10 - 11

44. Sotalol

    Newsletter Article 12 February 2013 Pages: 11 - 11

45. Streptokinase

    Newsletter Article 12 February 2013 Pages: 11 - 11

46. Sulfasalazine/mesalazine

    Newsletter Article 12 February 2013 Pages: 11 - 12

47. Tobramycin

    Newsletter Article 12 February 2013 Pages: 12 - 12

48. Tretinoin

    Newsletter Article 12 February 2013 Pages: 12 - 12

49. Vaccine, hepatitis B

    Newsletter Article 12 February 2013 Pages: 12 - 12

50. Vecuronium

    Newsletter Article 12 February 2013 Pages: 12 - 12